MedPath
NMPA Approval

Olopatadine Hydrochloride Eye Drops

国药准字H20183349

July 13, 2023

Drug Information

盐酸奥洛他定滴眼液

远清

眼用制剂

0.1%(5ml:5mg,以C21H23NO3计)

化学药品

July 13, 2023

Company Information

Applicant Company

江苏省南通市开发区新景路19号

Manufacturing Company

江苏省南通市开发区新景路19号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸奥洛他定滴眼液 - NMPA 批准文号 | MedPath